Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients

NCT03667014 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03667014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2018
Completion date
December 15, 2022
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, atopic dermatitis eczema